PDMR Notification

AI SummaryClose X

Poolbeg Pharma plc announced a PDMR notification regarding Executive Chair Cathal Friel's shareholding. As Horizon Medical Technologies Limited, an investment vehicle in which Friel's company holds 89.5%, is being wound down, its 1,552,931 Poolbeg shares will be distributed. Specifically, 162,775 shares will go to independent 10.5% shareholders of Horizon, and the remaining 1,390,156 shares will be distributed to Friel's family vehicle, Raglan Road Capital Limited. Following this distribution, Cathal Friel's total beneficial shareholding remains unchanged at 41,056,982 ordinary shares, representing 5.82% of the issued share capital.

Disclaimer*

UK 100

Latest directors dealings